(Q52737161)

English

Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.

scientific article published in June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Eliza N Fung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Adela Buzescu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jianing Zeng

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

1 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1291-1304

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Current role of LC-MS in therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

LC-MS Development strategies for quantitative bioanalysis

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Stabilizing drug molecules in biological samples

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Factors Affecting the Stability of Drugs and Drug Metabolites in Biological Matrices

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Critical Topics in Ensuring Data Quality in Bioanalytical LC–MS Method Development

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Current progress on esterases: from molecular structure to function

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Acyl glucuronide drug metabolites: toxicological and analytical implications

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Post-column infusion study of the 'dosing vehicle effect' in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples

1 reference

https://api.crossref.org/works/10.1002%2FRCM.6230

21 January 2018

Identifiers

10.1002/RCM.6230

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555922%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52737161&oldid=2144940490"